ENO2 and chronic obstructive pulmonary disease: However, no significant differences in smoking, drinking, COPD, family history of cancer, BMI, histology, lesion, laterality, chemotherapy, radiotherapy, targeted therapy, CEA, or NSE were found among the three groups.